ACE inhibitors |
angiotensin-converting enzyme inhibitors |
Ang II |
angiotensin II |
BMI |
body mass index |
CC–IMT |
common carotid intima-media thickness |
DBP |
diastolic blood pressure |
DLA |
diameter of the left atrium |
ECM |
extracellular matrix |
ED |
endothelial dysfunction |
EDLV |
end diastolic diameter of left ventricle |
EDHF |
endothelial derived hyperpolarizing factor |
EF |
ejection fraction |
FMD |
flow-mediated vasodilatation |
HTN |
hypertension |
hs-CRP |
high-sensitivity C-reactive protein |
IVS |
interventricular septum |
MONO |
monocytes |
NEUTRO |
neutrocytes, neutrophils |
NO |
nitric oxide |
PAI |
platelet activator inhibitor |
PTX3 |
pentraxin-3 |
PWLV |
posterior wall of the left ventricle |
SD |
standard deviation |
SBP |
systolic blood pressure |
sGC |
soluble guanylatecyclase |
TGF |
transforming growth factor |
TSP-1 |
thrombospondin-1 |
VSMCs |
vascular smooth muscle cells |
WBC |
white blood cells |